Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

uniQure N.V. (QURE)

Pharmaceutical Preparations

https://www.uniqure.com

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

PAASHEUVELWEG 25A
AMSTERDAM, P7

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/05/2014

Market Cap

327,247,872

Shares Outstanding

47,810,000

Weighted SO

47,811,479

Total Employees

N/A

Upcoming Earnings

08/06/2024

Similar Tickers

RCKT --.--%

RYTM --.--%

SLDB --.--%

MGTX --.--%

TERN --.--%

AMLX --.--%

ABOS --.--%

INZY --.--%

XFOR --.--%

Beta

0.9640

Last Div

0.0000

Range

3.73-11.35

Chg

-0.0100

Avg Vol

2922659

Mkt Cap

327247872

Exch

NASDAQ

Country

NL

Phone

31 20 240 6000

DCF Diff

8.1358

DCF

-1.5009

Div Yield

0.0000

P/S

11.8110

EV Multiple

-2.4978

P/FV

3.3648

Div Yield %

0.0000

P/E

-1.1477

PEG

-0.1304

Payout

0.0000

Current Ratio

7.3566

Quick Ratio

7.3566

Cash Ratio

3.5775

DSO

103.4125

DIO

0.0000

Op Cycle

103.4125

DPO

50.5406

CCC

52.8719

Gross Margin

-0.1487

Op Margin

-8.8925

Pretax Margin

-10.1103

Net Margin

-10.2752

Eff Tax Rate

-0.0163

ROA

-0.3895

ROE

-1.5809

ROCE

-0.3788

NI/EBT

1.0163

EBT/EBIT

1.1369

EBIT/Rev

-8.8925

Debt Ratio

0.7143

D/E

5.3763

LT Debt/Cap

0.8422

Total Debt/Cap

0.8432

Int Coverage

-1190.2609

CF/Debt

-0.1983

Equity Multi

7.5262

Rec Turnover

3.5296

Pay Turnover

7.2219

Inv Turnover

0.0000

FA Turnover

0.6740

Asset Turnover

0.0379

OCF/Share

-2.1295

FCF/Share

-2.2668

Cash/Share

10.7858

OCF/Sales

-3.7371

FCF/OCF

1.0645

CF Coverage

-0.1983

ST Coverage

-28.5636

CapEx Coverage

-15.5139

Div&CapEx Cov

-15.5139

P/BV

3.3648

P/B

3.3648

P/S

11.8110

P/E

-1.1477

P/FCF

-2.9691

P/OCF

-3.1556

P/CF

-3.1556

PEG

-0.1304

P/S

11.8110

EV Multiple

-2.4978

P/FV

3.3648

DPS

0.0000

Latest Headlines (EST)

Benzinga Dec 19, 13:34 Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session GlobeNewswire Inc. Dec 08, 07:05 uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Nov 29, 07:05 uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease

Revenue Product Segmentation